Investors

Presentations & Reports 2024

2020

For investor-related information please contact Gabriella Hold at Automic Group
Ph: +61 411 364 382 E: gabriella.hold@automicgroup.com.au

Zelira Therapeutics FY24 AGM Presentation

Chairman Mr. Osagie Imasogie and CEO Dr. Oludare Odumosu deliver commentary on key milestones achieved in FY24 and the priorities and outlook for the company.

Investor Webinar – Update on Zelira’s progress with the FDA pre-IND meeting and HOPE SPV

Chairman Mr Osagie Imasogie and Global CEO Dr Oludare Odumosu provide investors with an update on the recent progress with the FDA pre-IND meeting and next steps for the HOPE SPV. The formal presentation is followed by a Q&A session.

Zelira Annual Report 2024

Start typing and press Enter to search

Shopping Cart